Polycystic ovary syndrome (PCOS) is one of the most common reproductive endocrine
disorders in women and despite this, diagnostic challenges, delayed diagnosis, and less …

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women during
their reproductive ages, associated with a plethora of cardiometabolic consequences, with …

Objective This guideline will provide the practicing endocrinologist with an approach to the
assessment and treatment of dyslipidemia in patients with endocrine diseases, with the …

Polycystic ovary syndrome (PCOS) is a reproductive, endocrine, and metabolic disorder
affecting millions of women worldwide. Women with PCOS are often identified in …

Objective Polycystic ovary syndrome (PCOS) is associated with insulin resistance and
obesity. Prospective population-based data regarding development and possible predictors …

Polycystic ovary syndrome (PCOS) is a common hormonal condition with reproductive,
metabolic, and psychological sequelae. The Rotterdam Criteria are now internationally …

Background Polycystic ovary syndrome (PCOS) is associated with obesity and low grade
inflammation and the risk for cardiovascular disease (CVD) could be increased in PCOS …

Polycystic ovary syndrome is the most common endocrine disorder in women of
reproductive age. It is a complex disease in which genetic, endocrine, environmental, and …

The metabolic syndrome (MetS) comprises individual components including central obesity,
insulin resistance, dyslipidaemia and hypertension and it is associated with an increased …

Polycystic ovary syndrome (PCOS), characterized by hormonal imbalance and ovarian
dysfunction, often starts during adolescence. Inconsistent diagnostic criteria, variable …